The LifeScan Investigator-Initiated Study (IIS) Program helps investigators pursue and publish original research related to diabetes.
Evidence-based medicine is essential to improve the quality of life for people with diabetes. We know that today’s healthcare professionals and research scientists are key to tomorrow’s advances.
That is why LifeScan has proudly supported studies around the world for many years.
Currently, we are not accepting new applications for research funding.
We encourage investigators to learn more about the IIS Program and to review our online application.